SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
阿波罗光之子
Lv4
630 积分
2024-11-25 加入
最近求助
最近应助
互助留言
The mechanism and targeted intervention of the HIF-1 pathway in improving atherosclerotic heart's sensitivity to ischemic postconditioning
14小时前
已完结
Hypoxia exacerbates cardiomyocyte injury via upregulation of Wnt3a and inhibition of Sirt3
15小时前
已完结
CREB‐binding protein and HIF‐1α/β‐catenin to upregulate miR‐322 and alleviate myocardial ischemia‐reperfusion injury
2天前
已完结
CONTESSA TRIO: A multinational, multicenter, phase (P) II study of tesetaxel (T) plus three different PD-(L)1 inhibitors in patients (Pts) with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly pts with HER2-metastatic breast cancer (MBC)
26天前
已关闭
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
26天前
已完结
Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications
2个月前
已完结
Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications
2个月前
已完结
Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications
2个月前
已完结
In-silico identification and validation of Silibinin as a dual inhibitor for ENO1 and GLUT4 to curtail EMT signaling and TNBC progression
2个月前
已完结
Drugless nanoparticles tune-up an array of intertwined pathways contributing to immune checkpoint signaling and metabolic reprogramming in triple-negative breast cancer
2个月前
已完结
没有进行任何应助
感谢
14小时前
感谢
15小时前
感谢
2天前
感谢
26天前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论